Molecular design for recombinant adeno-associated virus (rAAV) vector production
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0614
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Molecular design for recombinant adeno-associated virus (rAAV) vector production ; volume:102 ; number:3 ; day:4 ; month:12 ; year:2017 ; pages:1045-1054 ; date:2.2018
Applied microbiology and biotechnology ; 102, Heft 3 (4.12.2017), 1045-1054, 2.2018
- Schlagwort
-
Infektion
Infektiologie
- Urheber
-
Aponte-Ubillus, Juan Jose
- Beteiligte Personen und Organisationen
-
Barajas, Daniel
Peltier, Joseph
Bardliving, Cameron
Shamlou, Parviz
Gold, Daniel
SpringerLink (Online service)
- DOI
-
10.1007/s00253-017-8670-1
- URN
-
urn:nbn:de:1111-2018032018468
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aponte-Ubillus, Juan Jose
- Barajas, Daniel
- Peltier, Joseph
- Bardliving, Cameron
- Shamlou, Parviz
- Gold, Daniel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Adeno-Associated Virus (AAV) vectors in gene therapy
Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Small but increasingly mighty: new insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Small but increasingly mighty: New insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Hepatotoxicity in Adeno-Associated Viral Vector Gene Therapy
Enhanced recombinant adeno-associated virus (rAAV) in vivo transduction efficacy via surface modified PAMAM nanoparticles precoating
Adeno-associated virus: from defective virus to effective vector
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Adeno-Associated Virus (AAV) vectors in gene therapy
Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Small but increasingly mighty: new insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Small but increasingly mighty: New insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Hepatotoxicity in Adeno-Associated Viral Vector Gene Therapy
Enhanced recombinant adeno-associated virus (rAAV) in vivo transduction efficacy via surface modified PAMAM nanoparticles precoating
Adeno-associated virus: from defective virus to effective vector
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Adeno-Associated Virus (AAV) vectors in gene therapy
Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Small but increasingly mighty: new insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Small but increasingly mighty: New insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Hepatotoxicity in Adeno-Associated Viral Vector Gene Therapy
Enhanced recombinant adeno-associated virus (rAAV) in vivo transduction efficacy via surface modified PAMAM nanoparticles precoating